|
⚲
|
| Keyboard |
| X4 Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001632304, 0001501697 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001501697] | |
| 10-Q | [0001501697] | |
| 3 | [0001501697] | |
| 4 | [0001501697] | |
| 8-K | [0001501697] | |
| D | [0001501697] | |
| SC 13D | [0001501697] | |
| SC 13G | [0001501697] | |
| D | [0001632304] | |
| SC 13D | [0001632304] | |
| SC 13G | [0001632304] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gold Kelly | |
| X4 Pharmaceuticals Inc | |
| Kirske David | |
| Bridger Gary | |
| Wyzga Michael S | |
| de Craecker Francoise | |
| Stewart Murray | |
| Volpone John | |
| Craig Adam R | |
| Thoren Natasha Fay | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2026-01-01 | Grant | 110,000 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 1,552,769 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 2,329,154 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-10-29 | Grant | 2,329,154 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-10-23 | Buy | 86,206 | $2.90 | 249,997 |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-08-14 | Grant | 289,881 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 352,800 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-08-14 | Grant | 289,881 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 529,201 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-08-14 | Grant | 193,254 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-14 | Grant | 529,201 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,609,873 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,609,873 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Stock Option (right to buy) · derivative
|
2025-08-12 | Grant | 1,073,249 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
|
X4 Pharmaceuticals Inc XFOR
Common Stock
|
2025-06-09 | Grant | 1,500 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||